Skip to main content
. 2011 Dec 20;21(7):1625–1638. doi: 10.1093/hmg/ddr600

Figure 8.

Figure 8.

Alternative MO injection strategies do not increase the survival beyond P0 ICV MO injection. Three cohorts of mice each received an injection of MO by P0 FV (50 µg/g body mass, n= 3), P0 FV and ICV (50 µg/g peripheral, 54 µg ICV, n= 5) or P0 and P30 ICV (with stereotactic guidance, 54 µg/g P0, 18 µg/g P30, n= 4). Survival for all groups was equivalent to high-dose P0 ICV MO injection (log-rank P> 0.09).